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Zika Virus
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Underlying Pathophysiology
Introduction
Zika virus (ZIKV) is a member of the
Spondweni serocomplex within the
genus Flavivovirus, family flaviviridae
(Weaver et. al, 2012). ZIKV is related to
dengue, West Nile, and yellow fever
viruses (Lazear et. al, 2016). ZIKV was
first discovered in Uganda, but since
then outbreaks have been reported in
Africa and Southeast Asia.
In May 2015, the Pan American
Health Organization (PAHO) issued an
alert regarding the first confirmed Zika
virus infection in Brazil, where it began
to rapidly spread throughout the region
(CDC, 2016). Recently, the World
Health Organization (WHO) declared
the ongoing outbreak of Zika virus and
associated complications in the
Americas, the Caribbean, and the
Pacific a Public Health Emergency of
International Concern (Coyle, 2016, p.
22). It is believed that the Zika virus
will likely continue to spread to new
areas (CDC, 2016).

Signs and Symptoms
According to Coyle (2016), eighty percent
of those infected with Zika virus will have
no symptoms, and those who are
symptomatic typically show signs that
include:

Low-grade fever
Maculopapular Rash
Conjunctivitis
Myalgia
Arthralgia
Headache
Malaise
(Weaver et al, 2016)
For the twenty percent that do exhibit
these symptoms, it is important to know
that the symptoms typically only last for
two to seven days.

ZIKV outbreak is very concerning,
due to the fact that there currently is
not a vaccine or antiviral treatment and
it has been linked to fetal mortality,
Guillain-Barre syndrome (GBS), and
encephalopathy (Johnson, 2016). This is
also a growing concern since many
individuals will be traveling from all
over the world to Brazil, who had their
first case of ZIKV last May, for the 2016
Summer Olympics.
The purpose of this subject matter
is to educate and spread awareness of
the disease process to help prevent the
disease from continuing to spread
throughout the world.

Zika virus is an arthropod-borne virus (arbovirus); arthropod
vectors include mosquitoes, ticks, and fleas. Once a mosquito is
infected with the virus, the virus replicates in the mosquito’s gut,
and passes the virus onto a human with its bite (Coyle, 2016,
p.22). Following a mosquito bite from an Aedes aegypti or Aedes
albopictus, keratinocytes and dendritic cells in the skin are
presumed to be the initial targets of ZIKV infections. Studies
have also showed that the phosphatidylserine receptor AXL can
act as a ZIKV entry receptor and for cellular autophagy in
enhancing ZIKV replication. This replication of ZIKV leads to
activation of an antiviral innate immune response and
production of type 1 interferons in infected cells (Hamel et. al,
2015). After the initial bite , viremia develops 1 to 5 days later,
and the virus is thought to be cleared within 2 weeks. ZIKV has a
positive-sense, single stranded RNA genome approximately 11
kilobases in length. The genome contains 5’ and 3’ untranslated
regions flanking a single open reading from (ORF) that encodes a
polyprotein that is cleaved into three structural proteins: the
capsid (C), premembrane/membrane (prM), and envelope (E),
and seven non-structural proteins (Haddow et al, 2012).

Figure 2. Zika Virus by Navy Marine Corps Public Health
Center and the Centers for Disease Control

Significance of Pathophysiology

Although the pathophysiology of ZIKV is not completely understood, the
complications that can arise from the virus are extremely alarming.
Recently, ZIKV has been linked to fetal immortality, microcephaly, and
Guillain-Barre syndrome.
Microcephaly:

Figure 1. Sick with chikungunya, dengue, or Zika?
By Centers for Disease Control and Prevention,
2016

Decreased occipitofrontal circumference
Abnormal brain development
Developmental delay; seizures; and speech, hearing, and
vision deficits
Infant mortality
Fetal loss in first trimester
Live births with rapid demise
Guillain-Barré syndrome
Autoimmune disease – attacks peripheral nervous system –
triggered by virus
Progressive limb weakness and often flaccid paralysis
Can be reversible, lead to long-term disability, or mortality
(Johnson, 2016)
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Implications for Nursing Care
Advanced practice nurses (APNs) could vastly impact
this issue by teaching the population ways to prevent the
virus from continuing to spread to new areas. Preventing
the disease from spreading can be achieved by educating
others.
Prevention:
Avoid mosquito bites – while traveling and after returning
for 3 weeks
•
Wear insect repellent
•
Wear long sleeved shirts and pants & spray with
permethrin
•
Sleep indoors
•
Outdoors use mosquito bed net
•
Avoid areas with standing water
Sexually Responsibili ty
•
Use condoms for 8 weeks after traveling to areas with
Zika to mitigate possible sexual transmission, if the
individual develops symptoms a condom should be
used for 6 months
•
Abstinence
(Coyle, 2016)
APNs must educate the population on the different
modes of transmission. This is important because it helps
inhibit individuals and mosquitos from acquiring the virus.
This will prevent the virus from being spread to new areas
and to more individuals.
Modes of Transmission:
•
Aedes Mosquito species bites – Mosquitos can
transmit to humans and non-infected mosquitos can
acquire virus from infected human
•
Sexual contact
•
Blood transfusion
•
Crossing placental barrier
(Coyle, 2016)

Conclusion
The Zika virus is a growing concern for
the world, as it continues to spread. The
fact that it is now linked to
microcephaly, fetal immortality, and
Guillain-Barre syndrome is worrisome.
Since there is not a vaccine or antivirals
available for the Zika virus, education
and public awareness are vitally
important to help prevent the virus from
continuing to spread throughout the
world.
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Another way APNs can help prevent Zika from
continuing to spread is by educating the population on the
different symptoms that are associated with the Zika virus.
It is important to recognize these symptoms and contact
your physician, where he/she may test urine or blood for
Zika.
Prevention is pivotal for controlling the spread of Zika,
due to the fact that there is not an antiviral or other
specific treatment available to treat the Zika virus.
However, APNs can offer supportive care for symptom
management (CDC,2016).
Supportive Care:
•
Rest
•
Fluids
•
Antipyretics
•
Analgesics

(Coyle, 2016)
For those who are infected, APNs can offer
counseling services regarding, fetal mortality, GBS, and
microcephaly
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Figure 3. Protect your family and community: How
Zika spreads. By Centers for Disease Control and
Prevention, 2016

